MERZ on the Move: Days After Ulthera Acquisition, Company Announces Plans for New Retinoid Therapy
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
Days after Ulthera acquisition, company announces plans to develop new Retinoid Therapy with Brickell Biotech.
The American Academy of Facial Plastic and Reconstructive Surgery has released its top five aesthetic trends for 2026, with a focus on regeneration, precision, and personalization.